Cumberland Pharmaceuticals Inc logo

Cumberland Pharmaceuticals Inc

$ 2.52 -0.08 (-3.08%) 10:08 PM EST
On watch
P/E:
At Loss
P/B:
0.95
Market Cap:
$ 36.95M
Enterprise V:
$ 39.42M
Volume:
14.95K
Avg Vol (2M):
9.38K
Also Trade In:
Volume:
14.95K
Market Cap $:
36.95M
PE Ratio:
At Loss
Avg Vol (2-Month):
9.38K
Enterprise Value $:
39.42M
PB Ratio:
0.95
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology and oncology. The company promotes its approved products through its hospital, field and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived primarily from the product sales of FDA approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ..
Name Current Vs Industry Vs History
Cash-To-Debt 0.93
Equity-to-Asset 0.43
Debt-to-Equity 0.49
Debt-to-EBITDA -6.56
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.67
Distress
Grey
Safe
Beneish M-Score -2.71
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 53.05
9-Day RSI 53.11
14-Day RSI 53.34
6-1 Month Momentum % -21.4
12-1 Month Momentum % -21.4

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.8
Quick Ratio 1.42
Cash Ratio 0.75
Days Inventory 394.63
Days Sales Outstanding 103.69
Days Payable 409.24

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 1.6

Financials (Next Earnings Date:2022-11-09 Est.)

CPIX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CPIX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 37.867
EPS (TTM) ($) -0.51
Beta 0.41
Volatility % 99.19
14-Day RSI 53.34
14-Day ATR ($) 0.200902
20-Day SMA ($) 2.461085
12-1 Month Momentum % -21.4
52-Week Range ($) 1.8901 - 7.51
Shares Outstanding (Mil) 14.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cumberland Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Cumberland Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.